Stock screenerAll disclosures →
EDGAR →
TSHA
Conviction 100HealthcareScan · Thu, Jun 25, 2026TSHA$6.21-10.52%
ResistanceSupportVol 14Insider sellVol MA14 4.73M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.21
Change-10.52%
Gap-2.59%
Rel volume11.02×
Avg volume3.89M
Avg $ vol23.53M
SMA 205.94
SMA 506.13
SMA 2004.95
Price vs 50+1.37%
Price vs 200+25.39%
MA stackbullish
50/200 cross—
Supertrendup · 5.75
RSI (14)53
MACD hist0.11
MACD crossbull · 7d
Stoch %K / %D53 / 78
ADX (14)22
+DI / −DI24 / 22
RSI divergence—
MACD divergence—
ATR %+6.92%
ADR %6.71%
52w high6.98
52w low2.31
From 52w high-11.03%
Above 52w low+168.83%
New 52w highNo
SqueezeOff
Bollinger width30.32%
%B0.65
Donchian pos52.91%
Donchian high7.06
Donchian low5.26
AVWAP (52w high)6.12
vs AVWAP high+1.52%
AVWAP (52w low)4.54
vs AVWAP low+36.70%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d11.02×
Avg vol (14d)4.73M
Avg vol (20d)3.89M
Avg $ vol (20d)23.53M
Market cap1.78B
RS 3m (vs SPY)+55.78%
RS 6m (vs SPY)+18.68%
RS line new highNo
Trend template8/8
Technical rank72.0
1 week+0.32%
1 month+11.09%
3 months+35.59%
6 months+5.97%
1 year+162.03%
YTD+18.29%
P/E-16.37
P/B8.42
P/S182.60
P/FCF-19.02
EPS-0.3400
Div yield—
ROE-51.43%
ROA-36.29%
Debt/Eq0.23
Current14.04
EV/EBITDA—
Gross margin—
Net margin—
Rev growth17.28%
EPS growth-22.06%
Price target12.50
Target upside101.29%
Analyst ratingBuy
Institutional99.13%
Ent. value1.56B
Revenue0
Net income-42.41M
Gross profit—
Free cash flow-93.83M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out287.36M
Employees99
ListedThu, Sep 24, 2020
Free float228.89M
Float %83.6%
Short interest36.01M
Days to cover16.4d
Short volume45.7%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.12 vs −$0.10
Last surprise-20.0% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank72.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.65
Support5.21
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TSHA
No recent disclosed trades by Congress in TSHA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TSHA · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Stalfort John A III Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Nagendran Sukumar President and Head of R&D · Common Stock · 2026-04-10 | Sell | 200K | $892K | 2026-04-10 | 2026-04-13 |
SEC filings
EDGAR filings in TSHA · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.